Related references
Note: Only part of the references are listed.SUMOylation proteins in breast cancer
Alaa T. Alshareeda et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study
Mohammed A. Aleskandarany et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS)
Ola H. Negm et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Anticancer Activities of PPARγ in Breast Cancer Are Context-Dependent
Jin-Tang Dong
AMERICAN JOURNAL OF PATHOLOGY (2013)
Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer
Alaa T. Alshareeda et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China
Xiao-Lei Wang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome
Mohammed A. Aleskandarany et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women
Maria Theresa M. Redaniel et al.
CANCER CAUSES & CONTROL (2012)
RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype
Hany Onsy Habashy et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
RPPanalyzer: Analysis of reverse-phase protein array data
Heiko A. Mannsperger et al.
BIOINFORMATICS (2010)
Role of Peroxisome Proliferator-Activated Receptor-γ and Its Coactivator DRIP205 in Cellular Responses to CDDO (RTA-401) in Acute Myelogenous Leukemia
Twee Tsao et al.
CANCER RESEARCH (2010)
PPARγ and Wnt/β-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations
Ying Jiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
PPARγ agonists inhibit growth and expansion of CD133+brain tumour stem cells
W. Chearwae et al.
BRITISH JOURNAL OF CANCER (2008)
Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance
Hany Onsy Habashy et al.
EUROPEAN JOURNAL OF CANCER (2008)
The Roles of Dietary PPAR gamma Ligands for Metastasis in Colorectal Cancer
Hiroki Kuniyasu
PPAR RESEARCH (2008)
PPAR gamma, PTEN, and the Fight against Cancer
Rosemary E. Teresi et al.
PPAR RESEARCH (2008)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Overview of nomenclature of nuclear receptors
Pierre Germain et al.
PHARMACOLOGICAL REVIEWS (2006)
Differential anti-proliferative actions of peroxisome proliferator-activated receptor-γ agonists in MCF-7 breast cancer cells
Ki Young Kim et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Peroxisome proliferator-activated receptor γ in human breast carcinoma:: a modulator of estrogenic actions
T Suzuki et al.
ENDOCRINE-RELATED CANCER (2006)
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
DM Abd El-Rehim et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance
JR Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPARγ fusion oncogene
WO Lui et al.
ONCOGENE (2005)
PPAR gamma expression in breast cancer: clinical value and correlation with ER beta
I Papadaki et al.
HISTOPATHOLOGY (2005)
Combining radiation and molecular targeting in cancer therapy
K Camphausen et al.
CANCER BIOLOGY & THERAPY (2004)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
Expression of peroxisome-proliferator activated receptor-gamma (PPARγ) and the PPAR-γ co-activator, PGC-I, in human breast cancer correlates with clinical outcomes
WG Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
PPARγ ligands and ATRA inhibit the invasion of human breast cancer cells in vitro
H Liu et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
The antiproliferative effects of PPARγ ligands in normal human mammary epithelial cells
LD Yee et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Novel therapeutic approach:: ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells
E Elstner et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Peroxisome proliferator-activated receptor gamma (PPAR gamma) and its ligands: A review
KL Houseknecht et al.
DOMESTIC ANIMAL ENDOCRINOLOGY (2002)
Nuclear receptors and lipid physiology: Opening the X-files
A Chawla et al.
SCIENCE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
